What Pharmaidea does

Pharmaidea (PHARM@IDEA S.R.L. A Socio Unico) is an Italian pharmaceutical distribution intermediary founded in 2000 and headquartered in Travagliato (Brescia), operating as a subsidiary of Petrone Group since 2013. The company functions as a strategic "trait d'union" between pharmaceutical manufacturers and Italian pharmacies, serving over 14,000 pharmacy clients through an omnichannel model that integrates a 60-person field agent network, a 20-operator remote sales call center, and the proprietary myPharmaidea digital platform. Pharmaidea holds 30+ mandates (mandati) from pharmaceutical companies, distributing 4,000+ product references from a single company-owned 5,000 sqm temperature-controlled, GDP-compliant warehouse located across two operational sites (Brescia and Naples).

The company's product portfolio spans two distinct categories. First, a suite of proprietary digital platforms: PhiSOS (24/7 SOS ordering for unavailable medicines), Phind (B2B marketplace with virtual storefronts), Phit (mobile training/simulation app for pharmacists), Phire (Decision Support System for targeting and customer activation), and Phix (targeted advertising showcase), all integrated within the myPharmaidea client portal. Second, a portfolio of proprietary consumer brands covering respiratory wellness (Sobrepin), gastrointestinal health (Isypan), anti-inflammatory care (NeoNisidina), lip care (Morbidì), and veterinary supplements and diagnostics (Vettys, launched as a startup in 2022). Pharmaidea also deploys 18 pharmaceutical sales representatives (Informatori Scientifici del Farmaco) to deliver medical-scientific information services to healthcare professionals.

Revenue is generated through product concessions and distribution commissions on behalf of pharmaceutical company mandates, sales of proprietary branded consumer health and OTC products, service fees from pharmaceutical company contracts (marketing, logistics, data analysis, scientific information), and platform-related service fees from pharmacies. Approaching €200 million in revenue as of 2025, with approximately 150 employees, the company participates in major European pharmaceutical industry trade shows including Cosmofarma, CPHI, and Pharmexpo, and is extending its omnichannel footprint via partnerships with cardiac telemedicine (Biotechware) and food delivery (Alfonsino) platforms.

Name

Pharmaidea

Legal name

PHARM@IDEA S.R.L. A SOCIO UNICO

Website

https://pharmaidea.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

101–250 employees

Short description

Pharmaidea is an Italian pharmaceutical distribution intermediary serving 14,000 pharmacies through an omnichannel model (60 field agents, 20 call center operators, digital platforms) and distributing 4,000+ product references on behalf of 30+ pharmaceutical company mandates, with approaching €200M in 2025 revenue.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

akta.pro secondary industries

Telepharmacy & Prescription Fulfillment Marketplaces (HLALALAF), Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD)

Keywords

• Pharmaceutical distribution services
• Pharmacy supply services
• Pharmaceutical marketing services
• OTC consumer health products
• Pharmaceutical logistics services

Headquarters

HQ city

Travagliato

HQ country

Italy

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Product Concessions: Pharmaidea acts as a strategic partner for pharmaceutical companies, managing product distribution through a multichannel network to 14,000 pharmacies. Revenue is generated through product concessions and sales commissions on products distributed on behalf of 30 pharmaceutical company mandates.
2. Proprietary Consumer Products: Pharmaidea manufactures and sells its own branded product lines including Sobrepin (respiratory wellness), Isypan (gastrointestinal wellness), Morbidi (lip care), Nisidina (anti-inflammatory), and Vettys (pet wellness). Revenue from branded consumer health and OTC products sold through pharmacies.
3. Services to Pharmacies: Services include competitive commercial offers, the PhiSOS urgent drug procurement service, Phind marketplace, and document management via myPharmaidea. Revenue model includes service fees and potentially subscription/usage-based components for the digital platform.
4. Services to Pharmaceutical Companies: Services for pharmaceutical companies include product concession management, marketing plan development, logistics (temperature-controlled warehouse, GDP-compliant packaging), data analysis and market reporting, and medical-scientific information via ISF. Revenue from service contracts with 30 pharmaceutical company mandates.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

Core offering

Pharmaidea is a strategic intermediary that distributes prescription drugs, OTC products, and parapharmaceuticals from 30 pharmaceutical company mandates to 14,000 pharmacies across Italy through an omnichannel model combining 60 field agents, a 20-operator inside sales call center, and proprietary digital platforms (PhiSOS, Phind, myPharmaidea). The company also manufactures and sells proprietary consumer health brands (Sobrepin, Isypan, NeoNisidina, Morbidì) and provides marketing, logistics, and scientific information services to pharmaceutical manufacturers from its 5,000 sqm GDP-compliant warehouse.

Product overview

Pharmaidea operates as a strategic pharmaceutical distribution partner serving over 14,000 pharmacies across Italy through an omnichannel model combining digital platforms, call centers, and a field agent network. The company offers two distinct portfolios: (1) a suite of digital platforms including PhiSOS (urgent medication ordering), Phind (B2B marketplace), Phit (pharmacist training app), Phire (decision support system), Phix (advertising platform), and myPharmaidea (unified client portal); and (2) proprietary consumer brands covering respiratory wellness (Sobrepin), gastrointestinal health (Isypan), anti-inflammatory treatment (NeoNisidina), lip care (Morbidì), and veterinary products (Vettys Integra and Vettys Pro).

Differentiator

Problem solved

Functional benefit

Brands

• Sobrepin: Product line for respiratory wellness for adults and children, treating conditions like dry and wet cough, nasal congestion, sore throat, COPD, and bronchitis
• Isypan
• NeoNisidina
• Morbidì
• Vettys
• PhiSOS
• Phind
• Phit
• Phire
• myPharmaidea

Products and services

• PhiSOS 24/7 SOS drug procurement service for Italian pharmacies to autonomously order temporarily unavailable medicines via a dedicated web platform, providing pharmaceutical companies with full visibility, control, and traceability of stock and orders.
• Phind B2B marketplace platform enabling pharmaceutical companies to sell directly to pharmacies with virtual storefront visibility, direct product access, direct feedback, detailed reporting, and customer experience management.
• Phit Mobile app for pharmacists combining training, simulation, and gamification to improve professional skills and product knowledge, delivering targeted educational content and increasing patient consultation opportunities.
• Phire Decision Support System (DSS) supporting pharmacy sales channels through targeting and multichannel capabilities, designed to increase active customers, reorder frequency, and product assortment.
• Phix Advertising platform providing a target-oriented virtual showcase for pharmaceutical products to support promotional and visibility campaigns.
• myPharmaidea Unified digital client portal that consolidates all Pharmaidea services for pharmacy clients, including PhiSOS (urgent drug orders), Phind (marketplace ordering), and document management for DDTs and invoices.
• Sobrepin Proprietary Pharmaidea product line for respiratory system wellness in adults and children, addressing dry and wet cough, nasal congestion, sore throat, COPD, and bronchitis.
• Isypan Proprietary Pharmaidea product line for gastrointestinal wellness, alleviating symptoms of digestive disorders and promoting natural balance of stomach and intestine.
• NeoNisidina Proprietary Pharmaidea product line for symptomatic treatment of mild to moderate pain, inflammatory conditions, and fever, with analgesic, antipyretic, and anti-inflammatory action.
• Morbidì Proprietary Pharmaidea line of 100% natural lip balms made with vegetable oils and vitamin E, with fruit-scented flavors promoting lip hydration, healing, and renewal.
• Vettys Integra Complementary feeds in practical kibble format developed for dog and cat wellness under the Vettys brand launched in January 2022 by Pharmaidea.
• Vettys Pro Rapid screening test line dedicated to veterinarians for quickly detecting common pathogens in dogs and cats, including pre-vaccination screening tests.

Quantifiable outcome

• 14,000 pharmacies served directly across Italy
• +3 more outcomes

Named customers2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Euromed PharmacoreStrategic or Co-development Partner · 1 October 2024Euromed Pharma is a sister company within the Petrone Group. Pharmaidea exhibits alongside Euromed Pharma at international trade events (CPHI Milan 2024, CPHI Frankfurt 2022), sharing a joint presence at major pharmaceutical industry trade shows.
• BiotechwarecoreStrategic or Co-development Partner · 10 October 2023Pharmaidea partnered with Biotechware, a leading company in cardiac telemedicine, to combine expertise, resources, and know-how for recognition as a top player in the Italian market for quality and reliability of products and services supplied to pharmacies. This collaboration represents a step into the 'pharmacy of services' and Point of Care for Pharmaidea, integrating telemedical diagnostic solutions with pharmacy distribution.
• AlfonsinominorGTM or Marketing Partner · 5 July 2023Pharmaidea partnered with Alfonsino, an Italian food delivery platform, to increase the range and use of 'Intolerant-Friendly' and 'Free From' products. Alfonsino users can purchase Pharmaidea's ISYPAN gastrointestinal wellness line and lactose-intolerance products directly through the Alfonsino app, accessing Pharmaidea's e-commerce platform with promotions and discounts.
• Vettys (Start-up)minorStrategic or Co-development Partner · 1 January 2022Vettys is a start-up launched by Pharmaidea in January 2022, specializing in dietary supplements for dogs and cats. Vettys develops complementary feed in practical kibble format and rapid screening tests for veterinarians. Pharmaidea acts as incubator/parent, with Vettys expanding coverage in Italian territory and pharmacy shelves through Pharmaidea's distribution network.
• Petrone GroupcoreStrategic or Co-development Partner · 1 January 2013Pharmaidea entered the Petrone Group in 2013, representing a turning point that allowed the company to expand its offerings and logistics capabilities. Petrone Group is the parent organization that includes sister companies Euromed Pharma (pharmaceutical services) and Pharma Call (contact center services). Pharmaidea exhibits together with Petrone Group sister companies at trade shows including CPHI Frankfurt 2022 (Stand D81 Hall 9.1).
• Fondazione Francesca Rava - N.P.H. Italia OnlusminorOthersPharmaidea supports the 'In Farmacia per i Bambini' initiative, a national campaign organized by Fondazione Francesca Rava for 20+ years to help children in health poverty. The campaign involves Italian pharmacies collecting medicines and baby-care products for children in family homes and communities in difficulty. Pharmaidea promotes and supports this initiative as part of its corporate social responsibility.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Phoenix Group: Pan-European pharmaceutical distribution group (parent of Comifar and Admenta Italia). Operates broadly across multiple European markets and product categories; offers overlapping capabilities in pharmaceutical wholesale and pharmacy services as part of a wider portfolio.
• McKesson Corporation: Global pharmaceutical distribution and healthcare services giant, parent of Celesio and Lloyds Pharmacy. Operates across many countries and segments; provides overlapping pharmaceutical distribution and digital pharmacy capabilities as part of a much broader portfolio.
• Walgreens Boots Alliance: Global pharmacy-led health and wellness enterprise and parent of Alliance Healthcare Italia. A broader incumbent with overlapping pharmaceutical distribution, retail pharmacy, and digital health capabilities across multiple geographies.

Direct peers

• Farvima S.p.A. Italian pharmaceutical wholesaler and distributor serving pharmacies nationwide. Direct competitor with overlapping product portfolio, customer base, and distribution model.
• Alliance Healthcare Italia: Italian subsidiary of Walgreens Boots Alliance and one of the largest pharmaceutical wholesalers in Italy, distributing to community pharmacies. Direct competitor to Pharmaidea in the same product category with similar customer base and business model.
• Unifarm S.p.A. Italian pharmaceutical cooperative distributor serving member pharmacies across Italy. Directly comparable to Pharmaidea in the B2B pharmaceutical distribution model to community pharmacies.
• Comifar Distribuzione S.p.A. Italian pharmaceutical distribution subsidiary of the Phoenix Group, one of the largest pharma distribution groups in Italy. Directly comparable in scale, customer base, and B2B distribution model.
• So.Farma.Morra S.p.A. Italian pharmaceutical wholesaler with national distribution to community pharmacies, headquartered in Naples. Overlaps with Pharmaidea's pharmacy customer base and wholesale distribution model.
• CEFA (Cooperativa Esercenti Farmacia): Italian pharmaceutical cooperative serving member pharmacies through centralized distribution and services. Comparable in its cooperative B2B model serving community pharmacies across Italy.

Emerging players

• DocMorris N.V. European online pharmacy and digital healthcare platform with B2C focus and growing B2B pharmacy services. Partial overlap with Pharmaidea's digital platform strategy (Phind marketplace) and pharmacy services orientation, but operating a different end-customer model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pharmaidea-srl

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmaidea